32 results
DEFM14A
AGIO
Agios Pharmaceuticals Inc
11 Feb 21
Proxy related to merger
4:19pm
;
any and all raw materials (including all bulk active pharmaceutical ingredients, constituent substances, materials, biomaterials (including study … property, other than tangible personal property that is a purchased asset;
any and all raw materials, work-in-process, finished goods, supplies
PREM14A
AGIO
Agios Pharmaceuticals Inc
29 Jan 21
Preliminary proxy related to merger
4:22pm
) of the oncology business as of immediately prior to the completion of the transaction, other than cash and cash equivalents;
any and all raw materials (including … tangible personal property that is a purchased asset;
any and all raw materials, work-in-process, finished goods, supplies and other inventories, other
8-K
EX-2.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
, financial or capital or credit market conditions or trends (including interest rates or the price of commodities or raw materials), including … as of immediately prior to the Closing, other than Cash Amounts (the “Business Current Assets”);
(e) Any and all raw materials (including all bulk active
DEFA14A
EX-2.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Additional proxy soliciting materials
9:17pm
, financial or capital or credit market conditions or trends (including interest rates or the price of commodities or raw materials), including … as of immediately prior to the Closing, other than Cash Amounts (the “Business Current Assets”);
(e) Any and all raw materials (including all bulk active
8-K
EX-99.1
g080h d5zdk94nk
29 Jan 21
Index to Consolidated Financial Statements
4:08pm